CLASS II Drug recall · Reported 3 Jun 2015 · FDA Enforcement Report

Acarbose Tablets 50 mg a) Unit Dose Tablets per, b) recalled

Boehringer Ingelheim Roxane is recalling Acarbose Tablets 50 mg a) Unit Dose Tablets per, b), distributed nationwide in the US. The recall was initiated on 2 Apr 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) Lot # 460073A Exp 04/2016 b) Lot # 460073B Exp 04/2016
NDC0054-0140, 0054-0141, 0054-0142
UPC0300540140250
Quantity recalleda) 575 Blister Packs, b) 12,802 Bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1085-2015
FDA event ID
70990
Recalling firm
Boehringer Ingelheim Roxane, Columbus, OH
Manufacturer
Hikma Pharmaceuticals USA Inc.
Classification
Class II
Status
Completed
Recall initiated
2 Apr 2015
FDA classified
27 May 2015
Reported
3 Jun 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

2 Apr 2015Recall initiated by company
27 May 2015Classified by FDA+55 days
3 Jun 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.

Which lots are affected?

a) Lot # 460073A Exp 04/2016 b) Lot # 460073B Exp 04/2016

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Boehringer Ingelheim Roxane

All 15

Other Acarbose recalls

All 4